SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending amidst a sharp price decline that has pushed it below key support levels, igniting fervent debate within the community; bears are proclaiming a "death spiral" and predicting much lower prices, while others see it as a generational buying opportunity in the ongoing "crypto winter."

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending following a steep price drop driven by broader crypto market weakness, notably Bitcoin's decline; the community is actively debating whether this is an institutional "buy the dip" opportunity or a further crash, with some even discussing the highly speculative "Epstein files" as a contributing factor.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending due to Bitcoin's sharp price decline, which has deepened the company's unrealized losses on its significant crypto holdings, fueling intense community debate over potential "liquidation" or "bankruptcy" while others see a "buy the dip" opportunity ahead of its anticipated earnings.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst sharp debate following its launch of a multi-cancer early detection test and its aggressive stance in the weight-loss medication market. Bulls anticipate significant growth from these initiatives, viewing current price action as an oversold opportunity and potential short squeeze, while bears are exasperated by persistent selling and concerns over competitive dynamics.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending after strong Q4 earnings, notably robust growth in Google Cloud and Search driven by AI, yet the market is debating its significantly increased capital expenditure guidance for 2026, with some seeing it as a strategic investment for AI dominance and others as an overextension.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending amidst a significant downturn in the cryptocurrency market, particularly Bitcoin, which is heavily impacting the stock as the community actively debates its strong correlation to digital assets and anticipates upcoming earnings.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending lower amid worse-than-expected jobless claims data and a broad sell-off in tech and software stocks, fueled by community debate over the high capital expenditures and uncertain returns on AI investments. The market is also reacting to a significant drop in Bitcoin, seen as a risk-off signal, as participants assess whether tech valuations are sustainable or if further downside is likely.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility and strong bearish sentiment, driven by rising jobless claims and the largest number of January job cuts since 2009, alongside broad weakness in the tech sector and a notable crash in cryptocurrency markets.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending due to widespread anticipation for its upcoming earnings report, with community sentiment sharply divided on whether strong AWS cloud growth driven by AI investments and holiday sales can offset concerns over significant capital expenditures and broader tech market volatility.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending following its Q4 earnings beat, which showed improved profitability, positive free cash flow, and a new share repurchase authorization, prompting many to expect a substantial rebound. However, mixed analyst ratings and ongoing concerns about user growth in core markets temper investor sentiment.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 5.8% - Here's What Happened

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 5.8% - Should You Sell...

ArriVent BioPharma (NASDAQ:AVBP) Shares Up 8.2% - What's Next?

ArriVent BioPharma (NASDAQ:AVBP) Shares Up 8.2% - What's Next...

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 7.4% - Here's What Happened

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 7.4% - Time to Sell...

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 3.2% - What's Next?

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 3.2% - Time to Sell...

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the stock, Marketbeat.com...

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 5.6% - Here's What Happened

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 5.6% - Time to Sell...

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B PR Newswire VANCOUVER, BC, Dec. 16, 2025 Issued on...

Fund 1 Investments LLC Acquires New Position in ArriVent BioPharma, Inc. $AVBP

Fund 1 Investments LLC bought a new position in shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The...

BTIG Research Upgrades ArriVent BioPharma (NASDAQ:AVBP) to "Strong-Buy"

BTIG Research upgraded shares of ArriVent BioPharma to a "strong-buy" rating in a report on Wednesday...

What is Lifesci Capital's Estimate for AVBP FY2025 Earnings?

ArriVent BioPharma, Inc. (NASDAQ:AVBP - Free Report) - Investment analysts at Lifesci Capital cut their FY2025 earnings per share (EPS) estimates for ArriVent BioPharma in a research note issued on...

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

ArriVent BioPharma Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $AMZN earnings on Thursday?

Current Price	$22.03
Prev Close	$22.64
Open	$21.65
Dividend Yield	0.00%
50-Day Moving Average	$22.28
Beta	0.91
Avg. Volume	417,604.60
PE Ratio	-5.20

52-Week High	$29.57
52-Week Low	$15.47
Market Capitalization	$909.43M
EPS (Annual)	-$2.39
Price to Book	2.95
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

AVBP
ArriVent BioPharma Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AVBP News

AVBPArriVent BioPharma Inc.